Global Medical Affairs Director, Benlysta
GSK Is a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
We have a significant global presence with commercial operations in more than 150 countries, a network of 89 manufacturing sites, and large R&D centers in the UK, USA, Belgium and China.
At GSK we are leaders in what we do - our pharmaceuticals business is made up of innovative and established medicines and holds leading positions in respiratory disease and HIV, in 2015 we distributed more than 690 million doses of vaccines to over 150 countries, and our Consumer Healthcare group has a portfolio of some of the world's most trusted and bestselling brands.
As a company our mission is to help people do more, feel better, live longer.
Within our R&D function, our Franchise model provides a lean organization with faster, higher-quality, decision making. This results in enhanced access for patients to new products via successful and sustainable launches across multiple LOCs.
To support our continuing stream of product launches and global medical affairs activities, we are looking to appoint a Benlysta medical director to work within the immunology / rheumatology area.
Benlysta is the only approved medicine for treating systemic lupus erythematosus in over 50 years. Benlysta is addressing a significant unmet medical need in the treatment of lupus.
Benlysta was initially launched as an IV formulation in 2011, with steady, successful growth In the US and internationally including recent approvals and launches of a subcutaneous auto-injector in the US and other global markets.
The global growth of Benlysta has been proceeding with many new and ongoing launches of both the intravenous and subcutaneous formulation.
Global Medical Director, Benlysta, lmmuno-lnflammation Global Medical Affairs
Key member of the Benlysta Global Medical team.
Leadership role in terms of global strategy and execution reporting to GMAL Benlysta.
Works in partnership with country teams to create and then implement global medical affairs strategies.
Seeks opportunities to bring in external and internal insights to shape strategy and drive medical execution.
Works together with commercial, R&D, and other key stakeholders to shape the life-cycle : management plan for Benlysta
Turns current and emerging evidence into content of value to both internal and external audiences
In collaboration with country teams develops a strong external network of global experts in Lupus
Supporting the Benlysta Global MA team and the global medical affairs leader with the following activities
Engages with senior stakeholders in assigned LOCs to facilitate launches and ongoing support of IV and subcutaneous Benlysta where already available, including reviewing and optimising medical affairs tactical plans and sharing learning / best practice.
Ensures country medical affairs colleagues have a robust knowledge of the relevant and emerging clinical evidence, supporting their continuous training by creating high quality scientific engagement materials for both internal and external use as well as directly supporting when needed
Partner with Marketing, Market Access and core country teams to generate content of high scientific quality for promotional use including at international congresses
Speaks at internal and external engagements as a subject matter expert on SLE and belimumab
Partners with assigned LOCs to drive-excellence in external engagement with key stakeholders (HCP's, Patients, Payors and Regulators).
Builds strong external networks and global external expert strategy
Partners with other above-country and country colleagues to bring in medical insights from across assigned LOCs and integrates / prioritises these to inform global medical affairs plans
Works with R&D, VEO, other disciplines, and country teams to identify evidence generation needs and plans to address them.
Areas include : lupus, other indications, mechanistic, value evidence, real world outcomes, and many others
Brings country medical affairs insights from the assigned geography to bear in discussions with R&D and commercial to shape the life-cycle management strategy for belimumab
Develop internal and external communication content on a vast array of disease-specific and Benlysta specific topics to address internal and external needs.
Can work with traditional and novel channels of communication.
Basic Qualifications :
We are looking for professionals with these required skills to achieve our goals :
GMC registered physician with specialist training in rheumatology
Broad drug development expertise-with robust knowledge of regulatory / market access and reimbursement requirements.
Considerable experience in Medical Affairs in relevant therapeutic area(s), including launch / peri-launch support requirements.
Robust understanding of internal (where applicable) and external promotional codes of practice and regulations.
Demonstrated ability to assess evidence generation needs
Track record of building strong internal and external networks.
Demonstrated ability to manage complexity and cultural diversity.
Previous cross-portfolio and above-country experience preferred.
Strong English communication skills both verbal and written a must
Preferred Qualifications :
If you have the following characteristics, it would be a plus :
Physician with specialist qualification in immunology / rheumatology